4/A//SEC Filing
TUCHMAN ALAN J 4/A
Accession 0001104659-22-123798
CIK 0001571934other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 7:46 PM ET
Size
6.0 KB
Accession
0001104659-22-123798
Insider Transaction Report
Form 4/AAmended
TUCHMAN ALAN J
DirectorChief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-15+68,850→ 68,850 totalExercise: $6.07Exp: 2032-11-15→ Common Stock, par value $0.0001 per share (68,850 underlying)
Footnotes (2)
- [F1]This filing amends the Form 4, filed on November 17, 2022 by Mr. Tuchman to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended.
- [F2]These options vested 50% on November 15, 2022 (the "Issuance Date") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer.
Documents
Issuer
Synaptogenix, Inc.
CIK 0001571934
Entity typeother
Related Parties
1- filerCIK 0001417631
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 7:46 PM ET
- Size
- 6.0 KB